Subscribe to our Newsletters !!

    drug development innovation

    Inhalation Sciences receives new IRS orders from returning customers

    Inhalation Sciences AB today announces that the company has received two new orders for a total value of EUR 27,400. The orders come from returning customers who have chosen to re-order IRS (Inhalation Research Services) studies via ISAB’s advanced exposure platforms PreciseInhale® and DissolvIt® for ongoing preclinical inhalation studies. In recent weeks, ISAB has received

    2026 Watchlist: Top 10 CROs Driving Innovation in Drug Development

    The role of AI in research promises to bring new drugs to market faster than ever before. Drug development is complex. As a result, many of the best contract research organizations (CROs) have stopped being simple vendors or service delivery partners. They have become partners in strategic innovation. The CRO Leaders to Watch in 2026: